MicroRNA-152 Suppresses Human Osteosarcoma Cell Proliferation and Invasion by Targeting E2F Transcription Factor 3

Area of Science:

• Oncology
• Molecular Biology
• Biochemistry

Background:

• Osteosarcoma (OS) is a primary bone malignancy with limited therapeutic options.
• MicroRNA-152 (miR-152) has been reported as downregulated in OS, but its functional role remains unclear.

Purpose of the Study:

• To investigate the function and molecular mechanism of miR-152 in osteosarcoma.
• To explore miR-152 as a potential therapeutic target for OS.

Main Methods:

• Quantitative real-time PCR to assess miR-152 expression in OS tissues and cell lines.
• Cell proliferation, colony formation, migration, and invasion assays to evaluate miR-152 function.
• Bioinformatics analysis and dual-luciferase reporter assay to identify and validate miR-152 targets.
• Western blot to assess protein expression levels.

Main Results:

• miR-152 expression was significantly downregulated in OS tissues and cell lines.
• Reduced miR-152 levels correlated with lymph node metastasis and advanced clinical stage.
• Overexpression of miR-152 suppressed OS cell proliferation, colony formation, migration, and invasion.
• miR-152 directly targets E2F transcription factor 3 (E2F3).
• E2F3 expression was upregulated in OS and inversely correlated with miR-152.
• E2F3 overexpression attenuated the inhibitory effects of miR-152 on OS cells.

Conclusions:

• miR-152 inhibits osteosarcoma growth and invasion by targeting E2F3.
• miR-152 acts as a tumor suppressor in osteosarcoma.
• miR-152 represents a potential therapeutic target for osteosarcoma treatment.